130 related articles for article (PubMed ID: 23047782)
1. The effect of a large regional health plan's value-based insurance design program on statin use.
Frank MB; Fendrick AM; He Y; Zbrozek A; Holtz N; Leung S; Chernew ME
Med Care; 2012 Nov; 50(11):934-9. PubMed ID: 23047782
[TBL] [Abstract][Full Text] [Related]
2. Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.
Maciejewski ML; Wansink D; Lindquist JH; Parker JC; Farley JF
Health Aff (Millwood); 2014 Feb; 33(2):300-8. PubMed ID: 24493774
[TBL] [Abstract][Full Text] [Related]
3. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
Sedjo RL; Cox ER
Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
[TBL] [Abstract][Full Text] [Related]
4. The impact of reducing cardiovascular medication copayments on health spending and resource utilization.
Choudhry NK; Fischer MA; Avorn JL; Lee JL; Schneeweiss S; Solomon DH; Berman C; Jan S; Lii J; Mahoney JJ; Shrank WH
J Am Coll Cardiol; 2012 Oct; 60(18):1817-24. PubMed ID: 23040581
[TBL] [Abstract][Full Text] [Related]
5. Impact of statin copayments on adherence and medical care utilization and expenditures.
Gibson TB; Mark TL; Axelsen K; Baser O; Rublee DA; McGuigan KA
Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486
[TBL] [Abstract][Full Text] [Related]
6. Value-based insurance design yields near- and long-term improvements in medication adherence.
Collado M
Find Brief; 2013 Mar; 16(1):1-3. PubMed ID: 23539769
[TBL] [Abstract][Full Text] [Related]
7. Copayment reductions generate greater medication adherence in targeted patients.
Maciejewski ML; Farley JF; Parker J; Wansink D
Health Aff (Millwood); 2010 Nov; 29(11):2002-8. PubMed ID: 21041739
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).
Duru OK; Turk N; Ettner SL; Neugebauer R; Moin T; Li J; Kimbro L; Chan C; Luchs RH; Keckhafer AM; Kirvan A; Ho S; Mangione CM
J Gen Intern Med; 2015 Nov; 30(11):1645-50. PubMed ID: 25944019
[TBL] [Abstract][Full Text] [Related]
9. Patient-centered outcomes of a value-based insurance design program for patients with diabetes.
Elliott DJ; Robinson EJ; Anthony KB; Stillman PL
Popul Health Manag; 2013 Apr; 16(2):99-106. PubMed ID: 23405873
[TBL] [Abstract][Full Text] [Related]
10. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
Musich S; Wang S; Hawkins K
Popul Health Manag; 2015 Jun; 18(3):151-8. PubMed ID: 25247449
[TBL] [Abstract][Full Text] [Related]
11. Five features of value-based insurance design plans were associated with higher rates of medication adherence.
Choudhry NK; Fischer MA; Smith BF; Brill G; Girdish C; Matlin OS; Brennan TA; Avorn J; Shrank WH
Health Aff (Millwood); 2014 Mar; 33(3):493-501. PubMed ID: 24522551
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of value-based insurance design with a large retail employer.
Kim YA; Loucks A; Yokoyama G; Lightwood J; Rascate K; Serxner SA
Am J Manag Care; 2011 Oct; 17(10):682-90. PubMed ID: 22106461
[TBL] [Abstract][Full Text] [Related]
13. Connecticut's Value-Based Insurance Plan Increased The Use Of Targeted Services And Medication Adherence.
Hirth RA; Cliff EQ; Gibson TB; McKellar MR; Fendrick AM
Health Aff (Millwood); 2016 Apr; 35(4):637-46. PubMed ID: 27044964
[TBL] [Abstract][Full Text] [Related]
14. Medication adherence changes following value-based insurance design.
Farley JF; Wansink D; Lindquist JH; Parker JC; Maciejewski ML
Am J Manag Care; 2012 May; 18(5):265-74. PubMed ID: 22694064
[TBL] [Abstract][Full Text] [Related]
15. Impact of decreasing copayments on medication adherence within a disease management environment.
Chernew ME; Shah MR; Wegh A; Rosenberg SN; Juster IA; Rosen AB; Sokol MC; Yu-Isenberg K; Fendrick AM
Health Aff (Millwood); 2008; 27(1):103-12. PubMed ID: 18180484
[TBL] [Abstract][Full Text] [Related]
16. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
17. Value-based insurance design: embracing value over cost alone.
Fendrick AM; Chernew ME; Levi GW
Am J Manag Care; 2009 Dec; 15(10 Suppl):S277-83. PubMed ID: 20088631
[TBL] [Abstract][Full Text] [Related]
18. The effect of incentive-based formularies on prescription-drug utilization and spending.
Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
[TBL] [Abstract][Full Text] [Related]
19. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation.
Zeng F; An JJ; Scully R; Barrington C; Patel BV; Nichol MB
Value Health; 2010; 13(6):846-52. PubMed ID: 20561344
[TBL] [Abstract][Full Text] [Related]
20. The effects of prescription drug copayments on statin adherence.
Gibson TB; Mark TL; McGuigan KA; Axelsen K; Wang S
Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
